Avid Bioservices
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Avid Bioservices generated cash of $10,952,000, which is more than the previous year. Cash used in financing activities reached the amount of $20,067,000 last year. Net change in cash is therefore -$786,000.
Cash Flow
| 2015 | -36.01M | -8.44M | 34.97M |
|---|---|---|---|
| 2016 | -39.59M | -8.79M | 41.79M |
| 2017 | -39.78M | -2.99M | 28.16M |
| 2018 | -26.76M | -19K | 22.25M |
| 2019 | -11.59M | 4.54M | -2.86M |
| 2020 | 5.82M | -3.81M | 1.09M |
| 2021 | 31.18M | -9.86M | 112.33M |
| 2022 | 9.46M | -56.41M | 3.19M |
| 2023 | -12.88M | -77.63M | 2.90M |
| 2024 | 10.95M | -31.80M | 20.06M |
CDMO Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 38.89M | 126.51M | 170.26M | 36.61M | 33.50M | 43.41M | 46.79M | 61.41M | 68.00M | 77.49M |
Operating activities | ||||||||||
Net income | -140.75M | 560K | 127.67M | 11.21M | -10.46M | -4.21M | -21.81M | -28.15M | -55.65M | -50.35M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 11.10M | 7.21M | 4.48M | 3.45M | 3.09M | 2.74M | 2.56M | 2.46M | 1.53M | 1.04M |
Stock-based compensation expense | 9.73M | 10.97M | 7.38M | 3.85M | 2.49M | 1.59M | 1.53M | 3.36M | 4.89M | 6.70M |
| Deferred income tax benefit | 9.73M | 10.97M | 7.38M | 3.85M | 2.49M | 1.59M | 1.53M | 3.36M | 4.89M | 6.70M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.10M | 2.24M | -1.70M | -10.23M | -1.23M | -3.62M | 1.30M | -8.44M | 6.90M | -2.22M |
Inventories | 13.53M | -17.84M | -14.19M | -988K | -4.32M | 1.70M | 16.97M | -16.91M | -8.83M | -1.82M |
Accounts payable | 7.13M | 964K | -943K | -608K | 802K | 2.12M | -4.01M | -3.30M | -3.52M | 3.27M |
Cash generated by operating activities | 10.95M | -12.88M | 9.46M | 31.18M | 5.82M | -11.59M | -26.76M | -39.78M | -39.59M | -36.01M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -31.80M | -77.63M | -56.41M | -9.86M | -3.81M | -1.50M | -3.01M | -1.50M | -9.32M | -9.04M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 6.04M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -31.80M | -77.63M | -56.41M | -9.86M | -3.81M | 4.54M | -19K | -2.99M | -8.79M | -8.44M |
Financing activities | ||||||||||
Common Stock Issued | 1.39M | 3.40M | 3.35M | 32.14M | 1.12M | 1.53M | 0 | 30.45M | 45.19M | 19.23M |
Payments for dividends | 0 | 0 | 0 | -4.45M | -4.32M | -4.32M | -4.32M | -4.27M | -4.13M | -3.35M |
Repurchases of common stock | 0 | 0 | 0 | -40.49M | 0 | 258K | 0 | 0 | 0 | 0 |
Repayments of term debt | 17.32M | -505K | -162K | -93K | -78K | -74K | -180K | -139K | 0 | -13K |
Cash used in financing activities | 20.06M | 2.90M | 3.19M | 112.33M | 1.09M | -2.86M | 22.25M | 28.16M | 41.79M | 34.97M |
Net Change In Cash | -786K | -87.62M | -43.74M | 133.65M | 3.11M | -9.91M | -4.53M | -14.61M | -6.58M | -9.48M |
Cash at end of period | 38.10M | 38.89M | 126.51M | 170.26M | 36.61M | 33.50M | 42.26M | 46.79M | 61.41M | 68.00M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |